Scientists Map Complete Molecular Blueprint of Circulating Extracellular Vesicles
Comprehensive analysis of 140+ plasma samples reveals 182 core proteins and 52 lipids that define circulating EVs in human blood.
Summary
Researchers analyzed over 140 human plasma samples to create the first comprehensive molecular map of extracellular vesicles (EVs) circulating in blood. Using advanced separation techniques and mass spectrometry, they identified 182 core proteins and 52 lipids that consistently define EVs across all samples. The study also discovered specific markers like ADAM10 protein and PS(36:1) lipid that can precisely distinguish EVs from other particles in blood. This molecular blueprint provides crucial insights into how these cellular messengers function in health and disease, potentially advancing EV-based diagnostics and therapies.
Detailed Summary
Extracellular vesicles (EVs) are tiny membrane-bound particles released by cells that serve as crucial messengers in the bloodstream, carrying proteins, lipids, and genetic material between tissues. Despite their importance in health and disease, the precise molecular composition of circulating EVs has remained poorly understood due to technical challenges in separating them from abundant blood proteins and lipoproteins.
Researchers from Baker Heart and Diabetes Institute analyzed plasma samples from over 140 individuals using high-resolution density gradient separation followed by mass spectrometry proteomics and lipidomics. This approach successfully enriched EVs while minimizing contamination from non-EV particles that typically outnumber EVs by six to seven orders of magnitude in plasma.
The comprehensive analysis revealed 182 proteins and 52 lipids that consistently appear across all EV samples, representing the core molecular blueprint of circulating EVs. Key proteins included ADAM10, STEAP23, and STX7, while essential lipids included phosphatidylserines (PS), phosphatidylinositol phosphates (PIPs), and phosphatidic acids (PAs). The team also mapped 151 surface proteins and identified biological pathways related to membrane trafficking, vesicle biogenesis, and cellular signaling.
Crucially, the researchers identified specific molecular markers that can precisely differentiate EVs from non-EV particles in plasma. ADAM10 protein and PS(36:1) lipid emerged as particularly reliable markers for EV identification. Machine learning analysis using these markers achieved high accuracy in distinguishing true EVs from contaminating particles.
These findings have significant implications for EV research and clinical applications. The molecular blueprint provides standardized markers for EV identification across studies, potentially improving reproducibility in EV research. For clinicians, this work advances the development of EV-based liquid biopsies for disease monitoring and opens new avenues for engineered EV therapeutics with improved circulation properties.
Key Findings
- Identified 182 core proteins consistently present across all circulating EV samples from 140+ individuals
- Mapped 52 essential lipids that define EV membrane composition, including PS, PIPs, and PAs
- Discovered 151 surface-accessible proteins on circulating EVs, revealing their interaction capabilities
- Established ADAM10 protein and PS(36:1) lipid as highly specific markers for EV identification
- Achieved >24,000-fold protein reduction from plasma while maintaining EV integrity and function
- Quantified ~4.2 × 10^9 EV particles per milliliter of plasma with mean diameter of 220.4 nm
- Created machine learning models that precisely distinguish EVs from non-EV particles using molecular signatures
Methodology
The study used high-resolution iodixanol-based density gradient separation on plasma from 140+ individuals across multiple cohorts. Mass spectrometry proteomics identified 4,631 proteins in EVs versus 1,678 in non-EV fractions, while lipidomics quantified 829 lipid species. Statistical analysis included principal component analysis, differential abundance testing with Benjamini-Hochberg correction, and machine learning classification models.
Study Limitations
The study focused specifically on small EVs (30-300 nm) and may not represent larger EV subtypes. While density gradient separation achieved significant enrichment, absolute EV purity cannot be guaranteed. The research was conducted on plasma samples and findings may not directly translate to other body fluids or tissue-specific EVs.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.